Application | Comment | Organism |
---|---|---|
drug development | the enzyme is an anti-HCV target to combat drug resistance. Cajanine derivatives are a class of anti-HCV agents downregulating the enzyme | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(E)-2-hydroxy-3-isopentyl-4-methoxy-6-styrylbenzoic acid | - |
Homo sapiens | |
(E)-2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-(2-phenylprop-1-enyl)benzoic acid | - |
Homo sapiens | |
(E)-2-hydroxy-4-methoxy-3-prenyl-6-(2-(thiophen-2-yl)vinyl)-benzoic acid | - |
Homo sapiens | |
(E)-3-(3,7-dimethylocta-2,6-dienyl)-2-hydroxy-4-methoxy-6-phenethylbenzoic acid | - |
Homo sapiens | |
(E)-3-c-6-hydroxy-4-methoxy-5-prenyl-2-styrylbenzoic acid | - |
Homo sapiens | |
(E)-3-methoxy-4-(3-methylbut-2-enyl)-5-styrylphenol | i.e. longistyline C | Homo sapiens | |
(E)-6-(2-chlorostyryl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-6-(2-methylstyryl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-6-(3-methylstyryl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-6-(4-fluorostyryl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-6-(4-hydroxystyryl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-6-(4-methylstyryl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-6-(but-1-enyl)-2-hydroxy-4-methoxy-3-prenylbenzoic acid | - |
Homo sapiens | |
(E)-ethyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-styrylbenzoate | - |
Homo sapiens | |
(E)-isopropyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-styrylbenzoate | - |
Homo sapiens | |
(E)-methyl 2-hydroxy-3-isopentyl-4-methoxy-6-styrylbenzoate | - |
Homo sapiens | |
(E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-(2-phenylprop-1-enyl)benzoate | - |
Homo sapiens | |
(E)-methyl 2-hydroxy-4-methoxy-3-prenyl-6-(2-(thiophen-2-yl)-vinyl)benzoate | - |
Homo sapiens | |
(E)-methyl 6-(2-chlorostyryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(2-methylstyryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(3-methylstyryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(4-(tert-butyldimethylsilyloxy)styryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(4-fluorostyryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(4-hydroxystyryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(4-methylstyryl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-(but-1-enyl)-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-methyl 6-styryl-2-hydroxy-4-methoxy-3-prenylbenzoate | - |
Homo sapiens | |
(E)-N-cyclopropyl-2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-styrylbenzamide | - |
Homo sapiens | |
(E)-tert-butyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-styrylbenzoate | - |
Homo sapiens | |
2-hydroxy-3-isopentyl-4-methoxy-6-phenethylbenzoic acid | - |
Homo sapiens | |
2-hydroxy-4-methoxy-3-prenyl-6-((1E,3E)-4-phenylbuta-1,3-dienyl)benzoic acid | - |
Homo sapiens | |
2-hydroxy-4-methoxy-3-prenyl-6-phenethylbenzoic acid | - |
Homo sapiens | |
cajanine | cajanine is a stilbenic component isolated from Cajanus cajan, it is identified as a potent hepatitis C virus (HCV) inhibitor by phenotypic screening with EC50 of 0.00317 mM. Cajanine inhibits HCV infection by targeting cellular CSGalNAcT-1 protein destabilizing the protein. Cajanine does not inhibit HCV replication at the replicative steps of HCV life cycle. CSGalNAcT-1 is important to support HCV replication at the early stage. Structure-activity relationships and the mechanism of action, and analysis of cajanine derivatives, EC50 values, overview. Cajanine might inhibit HCV replication at early steps of the viral life cycle via downregulating of cellular CSGalNAcT-1 | Homo sapiens | |
longistyline A | - |
Homo sapiens | |
methyl 2-hydroxy-4-methoxy-3-prenyl-6-((1E,3E)-4-phenylbuta-1,3-dienyl)benzoate | - |
Homo sapiens | |
methyl 2-hydroxy-4-methoxy-3-prenyl-6-phenethylbenzoate | - |
Homo sapiens | |
additional information | 2-hydroxy-4-methoxy-6-[(E)-2-phenylethenyl]benzoic acid is not inhibitory | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q8TDX6 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
Huh-7.5 cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 | - |
Homo sapiens |
CSGal-NACT-1 | - |
Homo sapiens |
CSGalNAcT1 | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | cajanine is a stilbenic component isolated from Cajanus cajan, it is identified as a potent hepatitis C virus (HCV) inhibitor by phenotypic screening with EC50 of 0.00317 mM. Cajanine inhibits HCV infection by targeting cellular CSGalNAcT-1 protein destabilizing the protein. Cajanine does not inhibit HCV replication at the replicative steps of HCV life cycle. CSGalNAcT-1 is important to support HCV replication at the early stage. Structure-activity relationships and the mechanism of action, and analysis of cajanine derivatives, overview. Cajanine might inhibit HCV replication at early steps of the viral life cycle via downregulating of cellular CSGalNAcT-1 | down |
General Information | Comment | Organism |
---|---|---|
malfunction | after silencing of endogenous CSGalNAcT-1 with specific siRNA, the intracellular hepatitis C virus (HCV) RNA load is largely reduced, and the HCV core protein is declined as well | Homo sapiens |
physiological function | CSGalNAcT-1 is essential for hepatitis C virus (HCV) replication in human cells | Homo sapiens |